How an ‘impossible’ idea led to a pancreatic cancer breakthrough
And now that the protein targeting strategy is showing promise, more companies have jumped into the fray. Dozens of similar drugs are now being tested for pancreatic, lung and colon cancer. The drug that opened the floodgates, daraxonrasib, has been fast-tracked for review by the Food and Drug Administration and could win approval later this […]
How an ‘impossible’ idea led to a pancreatic cancer breakthrough Read More »








